|
CA2829310A1
|
|
Cover for housing a syringe, assembly comprising such cover, pen-injector comprising such assembly and method for forming a pen-injector
|
|
ZA200601949B
|
|
Nicotine formulations and use thereof
|
|
BRPI0508894A
|
|
means for transdermal nicotine administration and use
|
|
CN1933822A
|
|
Means for transdermal administration of nicotine
|
|
EP1683537A1
|
|
Injection device for administering a medication liquid
|
|
EP1700613A1
|
|
Injection device for administering a medication liquid
|
|
EP1683538A1
|
|
Injection evice for administering a medication liquid
|
|
EP1667671A1
|
|
Enhanced method of treatment of growth disorders
|
|
CA2537488A1
|
|
Nicotine formulations and use thereof
|
|
BRPI0408655A
|
|
formulations comprising an active agent and cocoa powder and their use
|
|
MXPA05010314A
|
|
Formulations comprising tolterodine and cocoa powder and use thereof.
|
|
BRPI0407934A
|
|
method to produce a solid form of heparin
|
|
KR20050096147A
|
|
Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders
|
|
AU2003278503A1
|
|
Methods for predicting therapeutic response to agents acting on the growth hormone receptor
|
|
BR0314187A
|
|
Process for Producing Growth Hormone Crystals
|
|
PL374662A1
|
|
Dispensing apparatus and method for liquid products, particularly medicinal products
|
|
MXPA05000254A
|
|
Jet injector and method for its operation and production.
|
|
CA2494712A1
|
|
Device and method for liquid jet generation
|
|
KR20050047527A
|
|
New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof
|
|
BR0309375A
|
|
Treatment of metabolic syndrome
|
